SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Kang H,O'Connell JB,Leonardi MJ,Maggard MA,McGory ML,Ko CY. Rare tumors of the colon and rectum: a national review. Int J Colorectal Dis. 2007; 22: 183189.
  • 2
    Vinik AI,McLeod MK,Fig LM,Shapiro B,Lloyd RV,Cho K. Clinical features, diagnosis, and localization of carcinoid tumors and their management. Gastroenterol Clin North Am. 1989; 18: 865896.
  • 3
    Soga J. Carcinoids and their variant endocrinomas. An analysis of 11842 reported cases. J Exp Clin Cancer Res. 2003; 22: 517530.
  • 4
    Maggard MA,O'Connell JB,Ko CY. Updated population-based review of carcinoid tumors. Ann Surg. 2004; 240: 117122.
  • 5
    Modlin IM,Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer. 1997; 79: 813829.
  • 6
    Godwin JD2nd. Carcinoid tumors. An analysis of 2,837 cases. Cancer. 1975; 36: 560569.
  • 7
    Modlin IM,Lye KD,Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer. 2003; 97: 934959.
  • 8
    Newton JN,Swerdlow AJ,dos Santos Silva IM, et al. The epidemiology of carcinoid tumours in England and Scotland. Br J Cancer. 1994; 70: 939942.
  • 9
    Hemminki K,Li X,Plna K,Granstrom C,Vaittinen P. The nation-wide Swedish family-cancer database—updated structure and familial rates. Acta Oncol. 2001; 40: 772777.
  • 10
    Crocetti E. Gastrointestinal carcinoid tumours. A population-based study. Ital J Gastroenterol Hepatol. 1997; 29: 135137.
  • 11
    Westergaard T,Frisch M,Melbye M. Carcinoid tumors in Denmark 1978–1989 and the risk of development of new cancers [in Danish]. Ugeskr Laeger. 1996; 158: 3153315.
  • 12
    Hemminki K,Li X. Incidence trends and risk factors of carcinoid tumors: a nationwide epidemiologic study from Sweden. Cancer. 2001; 92: 22042210.
  • 13
    Crocetti E,Buiatti E,Amorosi A. Epidemiology of carcinoid tumours in central Italy. Eur J Epidemiol. 1997; 13: 357359.
  • 14
    Rorstad O. Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract. J Surg Oncol. 2005; 89: 151160.
  • 15
    Modlin IM,Kidd M,Latich I,Zikusoka MN,Shapiro MD. Current status of gastrointestinal carcinoids. Gastroenterology. 2005; 128: 17171751.
  • 16
    Shebani KO,Souba WW,Finkelstein DM, et al. Prognosis and survival in patients with gastrointestinal tract carcinoid tumors. Ann Surg. 1999; 229: 815821; discussion 822–823.
  • 17
    Onaitis MW,Kirshbom PM,Hayward TZ, et al. Gastrointestinal carcinoids: characterization by site of origin and hormone production. Ann Surg. 2000; 232: 549556.
  • 18
    Van Gompel JJ,Sippel RS,Warner TF,Chen H. Gastrointestinal carcinoid tumors: factors that predict outcome. World J Surg. 2004; 28: 387392.
  • 19
    Jetmore AB,Ray JE,Gathright JBJr,McMullen KM,Hicks TC,Timmcke AE. Rectal carcinoids: the most frequent carcinoid tumor. Dis Colon Rectum. 1992; 35: 717725.
  • 20
    TravisWD,BrambillaE,Muller-HermelinkHK,HarrisCC, eds. World Health Organization. Pathology and Genetics of Tumors of the Lung, Pleura, Thymus and Heart. Lyon, France: IARC Press; 2004.
  • 21
    HamiltonSR,AaltonenLA, eds.World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Digestive System.Lyon, France:IARC Press;2000.
  • 22
    Konishi T,Watanabe T,Kishimoto J,Kotake K,Muto T,Nagawa H. Prognosis and risk factors of metastasis in colorectal carcinoids: results of a nationwide registry over 15 years. Gut. 2007; 56: 863868.
  • 23
    Matsui K,Iwase T,Kitagawa M. Small, polypoid-appearing carcinoid tumors of the rectum: clinicopathologic study of 16 cases and effectiveness of endoscopic treatment. Am J Gastroenterol. 1993; 88: 19491953.
  • 24
    Weng YJ,Wang SS,Yang WG,Chao Y,Lai CR,Lee SD. Carcinoid tumors of the gastrointestinal tract in Chinese of Taiwan: an analysis of fifty cases [in Chinese]. Zhonghua Yi Xue Za Zhi (Taipei). 1996; 58: 254258.
  • 25
    Zhang SQ. Screening and prevention of colorectal cancer in Haining County. Dis Colon Rectum. 1985; 28: 300304.
  • 26
    Chan W,Fu KH. Value of routine histopathological examination of appendices in Hong Kong. J Clin Pathol. 1987; 40: 429433.
  • 27
    Soga J,Yakuwa Y,Osaka M. Evaluation of 342 cases of mediastinal/thymic carcinoids collected from literature: a comparative study between typical carcinoids and atypical varieties. Ann Thorac Cardiovasc Surg. 1999; 5: 285292.
  • 28
    Soga J. Carcinoids of the rectum: an evaluation of 1271 reported cases. Surg Today. 1997; 27: 112119.
  • 29
    Tichansky DS,Cagir B,Borrazzo E, et al. Risk of second cancers in patients with colorectal carcinoids. Dis Colon Rectum. 2002; 45: 9197.
  • 30
    Habal N,Sims C,Bilchik AJ. Gastrointestinal carcinoid tumors and second primary malignancies. J Surg Oncol. 2000; 75: 310316.
  • 31
    Gerstle JT,Kauffman GLJr,Koltun WA. The incidence, management, and outcome of patients with gastrointestinal carcinoids and second primary malignancies. J Am Coll Surg. 1995; 180: 427432.
  • 32
    Oberg K. Expression of growth factors and their receptors in neuroendocrine gut and pancreatic tumors, and prognostic factors for survival. Ann NY Acad Sci. 1994; 733: 4655.
  • 33
    Mani S,Modlin IM,Ballantyne G,Ahlman H,West B. Carcinoids of the rectum. J Am Coll Surg. 1994; 179: 231248.
  • 34
    Koura AN,Giacco GG,Curley SA,Skibber JM,Feig BW,Ellis LM. Carcinoid tumors of the rectum: effect of size, histopathology, and surgical treatment on metastasis free survival. Cancer. 1997; 79: 12941298.
  • 35
    Soga J,Yakuwa Y. Bronchopulmonary carcinoids: an analysis of 1,875 reported cases with special reference to a comparison between typical carcinoids and atypical varieties. Ann Thorac Cardiovasc Surg. 1999; 5: 211219.
  • 36
    Fink G,Krelbaum T,Yellin A, et al. Pulmonary carcinoid: presentation, diagnosis, and outcome in 142 cases in Israel and review of 640 cases from the literature. Chest. 2001; 119: 16471651.
  • 37
    Davila DG,Dunn WF,Tazelaar HD,Pairolero PC. Bronchial carcinoid tumors. Mayo Clin Proc. 1993; 68: 795803.
  • 38
    Blondal T,Grimelius L,Nou E,Wilander E,Aberg T. Argyrophil carcinoid tumors of the lung. Incidence, clinical study, and follow-up of 46 patients. Chest. 1980; 78: 840844.
  • 39
    Chalabreysse L,Gengler C,Sefiani S,Meyronet D,Thivolet-Bejui F. Thymic neuroendocrine tumors: report on 6 cases [in French]. Ann Pathol. 2005; 25: 205210.
  • 40
    Fukai I,Masaoka A,Fujii Y, et al. Thymic neuroendocrine tumor (thymic carcinoid): a clinicopathologic study in 15 patients. Ann Thorac Surg. 1999; 67: 208211.
  • 41
    Moran CA,Suster S. Neuroendocrine carcinomas (carcinoid tumor) of the thymus. A clinicopathologic analysis of 80 cases. Am J Clin Pathol. 2000; 114: 100110.
  • 42
    Moran CA. Primary neuroendocrine carcinomas of the mediastinum: review of current criteria for histopathologic diagnosis and classification. Semin Diagn Pathol. 2005; 22: 223229.
  • 43
    Tiffet O,Nicholson AG,Ladas G,Sheppard MN,Goldstraw P. A clinicopathologic study of 12 neuroendocrine tumors arising in the thymus. Chest. 2003; 124: 141146.
  • 44
    Goto K,Kodama T,Matsuno Y, et al. Clinicopathologic and DNA cytometric analysis of carcinoid tumors of the thymus. Mod Pathol. 2001; 14: 985994.
  • 45
    Li AF,Tsay SH,Liang WY,Li WY,Chen JY. Clinical significance of p16INK4a and p53 overexpression in endocrine tumors of the gastrointestinal tract. Am J Clin Pathol. 2006; 126: 856865.